129658-simple-red-square-icon-social-media-logos-l

It is important to talk to your healthcare team about what side-effects you may be experiencing.

You are able to learn more about side effects from the patient information leaflet which comes with your mediation or via the Yellow Card Scheme.

 

© 2018 www.DR-web.co.uk is the trading name of DesignRedefined.co.uk Ltd, All Rights Reserved, Registered in England & Wales No: 9945411

Hot Topics

Fast-Track London Will Only Work If We Keep Our Foot On The Accelerator

 

Have your say: contribute to the UN’s work to end TB, HIV and viral hepatitis in the WHO European Region.

 

The National Institute for Health and Care Excellence (NICE) Issues Positive Guidance for AbbVie’s MAVIRET

 

Blood samples from the 1950s help rewrite the history of hepatitis C.

 

Research on HIV cure: Mapping the ethics landscape.

 

Just because a partner has undetectable viral load, it doesn’t rule out the need for PrEP or PEP

 

London clinic’s 90% drop in infections could be replicated elsewhere

 

AbbVie’s MAVIRET® recommended for use within NHS Wales.

 

Amsterdam PrEP failure patient had unusual course of HIV infection

 

People with HIV not getting all the health checks they need

 

NHS strikes up a 'pay as you cure' deal for hepatitis C drug

 

Aquarius Population Health wins a prestigious SBEI grant from Innovate UK

DR_Logo

DR-web.co.uk

Pinterest black large Twitter black large tt blog issuu bhiva Picture2 01 02 03 04 05 08 07 10 11 12 13 14 15 16 profile 09 SVR _12 Picture1 PSP HCV_tile Picture2

#hepCtreat Insights

 

David Rowlands provides an in depth look at his treatment and care experience as well as breaking down the barriers placed on the disease due to stigma and challenging your perceptions on hepatitis C.

 

95c067_f6a7b585e6de4988ad0602e2a45a1ea2-mv2 Picture1 Picture2 NOhep-Logo-Big patient 909090 generic Digital Picture1 Twitter_Polls_showed_us 01